Liver cancer prognosis study
Part of Cancer, Digestive system clinical trials.
This study looks at the outlook for people with liver cancer who have not yet started any cancer treatment. It aims to learn more about how the disease progresses over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have been diagnosed with primary liver cancer (cancer that started in the liver)
- You have not yet had any treatment for your cancer (like surgery, radiation, or medication)
- You are willing to sign a consent form to participate
- You have not had another type of cancer in the past
- You do not have other serious health problems like heart, liver, or kidney failure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is collecting information on how well a treatment (likely TACE, a procedure to block the tumor's blood supply) works for people with liver cancer that cannot be removed by surgery. It aims to see how safe and effective it is for patients who haven't had treatment before or who have a first recurrence.
This study looks at your risk of developing liver cancer if you have hepatitis B. It uses your medical history and test results to give you a better idea of your risk and help guide next steps.
This trial uses a computer model to predict if your liver cancer might come back aggressively after surgery. If you are at high risk, you may receive additional treatment before surgery to lower that risk.
This study observes people with stomach cancer that has spread to the liver. It looks at how the disease progresses and how patients respond to their usual treatments over time.
This study is creating a database of people with liver cancer (including hepatocellular carcinoma and other types). It aims to collect health information and samples over time to better understand the disease and improve future care. If you join, you will be asked to provide blood and leftover tissue from surgery or biopsy, and to follow up with the research team.
This study compares two types of radiation therapy for people with early-stage primary liver cancer that hasn't spread. It aims to see which method is better at targeting the tumor while protecting healthy tissue.
Hear when a new Liver Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.